IP Library Patent Application 12579851
Patent Application
App. No. 12/579,851

Regulation of Human Transmembrane Serine Protease

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/579,851
Abstract

Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.

Claims (8)

1 . A preparation of antibodies that specifically bind to a polypeptide comprising the amino acid sequence shown in SEQ ID NO:12.

2 . The preparation of antibodies of claim 1 which are polyclonal.

3 . The preparation of antibodies of claim 1 which are monoclonal.

4 . The preparation of antibodies of claim 1 which are single-chain antibodies.

5 . A preparation of antibodies that specifically bind to a polypeptide comprising the amino acid sequence encoded by a cDNA insert contained within plasmid pCR11-TMSP3 (ATCC Accession No. PTA-3433).

6 . The preparation of antibodies of claim 5 which are polyclonal.

7 . The preparation of antibodies of claim 5 which are monoclonal.

8 . The preparation of antibodies of claim 5 which are single-chain antibodies.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2009
From: BAYER AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023536/0024 →